CClinicalTrials.gg
CompletedNCT06730399Updated Jan 8, 2025

Computer-assisted Cryotherapy After Total Knee Arthroplasty

An observational study in Osteo Arthritis Knee, sponsored by Martini Hospital Groningen. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-08.

Sponsored by Martini Hospital Groningen · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
106
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study was to investigate whether computer-assisted cryotherapy is effective in reducing postoperative pain and analgesics consumption, next to improving functional outcome and patient satisfaction after total knee arthroplasty (TKA). The hypothesis is that computer-assisted cryotherapy has positive effects on postoperative pain after TKA.

For this purpose a single-centre non-blinded trial was designed where two groups of patients were observed, a cold (cryotherapy) C-group and a regular (control) R-group. Depended on the week they were operated patients received either usual care (R-group) or computed-assesed- cryotherapy (odd or even week; week-on/week-off principle). Patients in the C-group received next to usual postoperative care computer-assisted cryotherapy for several hours a day during the first seven postoperative days (10-12 degrees Celcius).

Primary outcome was pain, monitored with the numerical rating scale for pain. Secondary outcomes were the use of opioid escape medication, function and swelling, monitored by active range of motion, timed up and go test and circumference measurements; several patient-reported outcome measures (short term 2 and 6 weeks; and longer term 6 and 12 months postoperative); and patient satisfaction, monitored by the numerical rating scale for satisfaction.

Read the detailed description

The study was conducted at the Orthopaedic Surgery Department of Martini Hospital, a teaching hospital in the Netherlands. All participants gave signed informed consent before participation. Patients with end-stage OA over the age of 18 who were scheduled for a TKA were invited to participate in this study. Exclusion criteria were rheumatoid arthritis, skin or other infections, vascular disease, other comorbidities on which cooling may have a negative effect, and strong preference for one of the treatment options. Patients were randomised into one of the two groups by a week-on/week-off principle. Patients who underwent TKA surgery in an even week received additional postoperative cryotherapy (C-group), those who had the surgery in an odd week received usual postoperative care (R-group). Surgery dates were scheduled in the usual way by the planning department of the hospital. Two weeks before surgery, patients were informed by phone as to which group they were assigned to. Both groups received the usual rapid recovery (RR) care and rehabilitation program, consisting of local infiltration analgesia during surgery, compressive bandaging for 24 h after surgery, and full weight-bearing mobilisation and active range of motion exercises starting on the day of surgery. Antibiotics were given preoperatively and postoperatively. All patients received thromboembolic prophylaxis for a period of six weeks. The Smith \& Nephew (Memphis, USA) posterior stabilized (PS) GENESIS II total knee system was used for the TKA.

For the CAC in the C-group, the ZAMAR ZHC-MG665A (ZAMAR, Vrsar, Croatia) was used during hospitalisation and the smaller CAC system ZAMAR ZT Cube (ZAMAR, Vrsar, Croatia) for the home situation. The CAC system was delivered to the patient's home before the day of the surgery. Both models had a touchscreen with pre-set programs, with parameters as shown in the cooling schedule. All patients received a personal cooling brace, the ZAMAR Wrap, which transferred cold onto the skin and deep tissue around the knee. Patients in the C-group were instructed to cool the operated knee during the first seven postoperative days. The schedule they received was based on a schedule used by Thijs et al. Patients were allowed to deviate from this schedule, but were asked to document the actual cooling time and temperature in a log.

02

Conditions studied

  • Osteo Arthritis Knee

Keywords

  • cryotherapy
  • TKA
  • postoperative rehabilitation
  • pain
  • recovery
  • opioid
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population is recruited from one large peripheral hospital in the Netherlands, the Martini Hospital.

Inclusion criteria

  • Patients scheduled for a primary TKA or UKA in the Martini Hospital.
  • Age ≥ 18 years

Exclusion criteria

Exclusion Criteria:

  • skin (or other) infections
  • rheumatoid arthritis
  • vascular disease
  • having a strong preference for one of the two treatment options
04

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
106 participants (actual)
Patient registry
No

Groups and cohorts

  • Cryotherapy group

    Postoperative treatment using computed-assisted-cryotherapy in the first week postoperative in addition to usual care

    Device: Computed-assisted-cryotherapy

  • Control group

    Postoperative treatment according to usual care

Interventions

  • DeviceComputed-assisted-cryotherapy

    cryotherapy device

05

What researchers measure

Primary outcomes

  1. Numeric rating scale (NRS) pain score in rest

    range 0-10, where a higher score indicates more pain

    Time frame: assessed at 6 weeks postoperative

Secondary outcomes

  1. Numeric rating scale (NRS) pain score in rest

    range 0-10, where a higher score indicates more pain

    Time frame: at baseline, daily during the first 7 days, after 2 weeks, and 6 and 12 months postoperative

  2. Numeric rating scale (NRS) pain scores while loading

    range 0-10, where a higher score indicates more pain

    Time frame: at baseline, daily during the first 7 days, after 2 and 6 weeks, and 6 and 12 months postoperative

  3. Opioid use

    The amount of opioid use in case of excessive pain

    Time frame: daily during the first week after surgery

  4. active Range of Motion

    in degrees

    Time frame: at baseline and at 6 weeks postoperative

  5. Timed Up and Go

    In seconds. Measure of functional mobility.

    Time frame: at baseline and at 6 weeks postoperative

  6. Knee circumference

    in centimeters

    Time frame: at baseline and at 6 weeks postoperative

  7. Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire

    Without the sports and recreation domain. Range 0-100, where a higher score indicates less symptoms.

    Time frame: preoperative and 2 and 6 weeks postoperative

  8. Work, Osteoarthritis en joint-Replacement Questionnaire (WORQ)

    Measure of work ability (functioning). Range 0-100, where a higher score indicates less functional limitations.

    Time frame: preoperative and 2 and 6 weeks postoperative

  9. EuroQol 5D (EQ5D) - 5 point Likert scale

    Index score (0-1, closer to 1 indicates better health related quality of life); visual Analogue Scale scale about the self-perceived health status (0-100, higher indicates better self-perceived health status).

    Time frame: preoperative and 6 and 12 months postoperative

  10. Oxford knee scores

    Range 0-48, where a higher score indicates less symptoms.

    Time frame: preoperative and 6 and 12 months postoperative

  11. KOOS-PS scores (Knee Injury and Osteoarthritis Outcome Score - Physical Function Short Form)

    Range 0-100, where a higher score indicates less symptoms

    Time frame: preoperative, and 6 and 12 months postoperative

  12. Numeric rating scale (NRS) satisfaction

    patient's satisfaction with the outcome after surgery at that time point, range 0-10, where a higher score indicates more satisfaction

    Time frame: 2 and 6 weeks postoperative, and 6 and 12 months postoperative

  13. anchor question: patient perceived change in pain

    the degree in which a patient experiences an improvement in pain compared to baseline (7 point Likert scale: much worse, worse, slightly worse, no change, slightly better, better, much better)

    Time frame: 6 and 12 months postoperative

  14. anchor question: patient perceived change in functioning

    the degree in which a patient experiences an improvement in functioning compared to baseline (7 point Likert scale: much worse, worse, slightly worse, no change, slightly better, better, much better)

    Time frame: 6 and 12 months postoperative

  15. Numeric rating scal (NRS) satisfaction cryotherapy

    Only for the patients who used the Computer-assisted-cryotherapy device: patient's satisfaction with cryotherapy. Range 0-10, where a higher score indicates more satisfaction.

    Time frame: 1 week postoperative

  16. Complications/Serious adverse events

    Keep record of the complications that occurred

    Time frame: from baseline until 12 months postoperative

06

Study locations

1 site
  • Martini Hospital
    Groningen, Netherlands
07

References and documents

Publications

  • Brouwers HFG, de Vries AJ, van Zuilen M, van Kouswijk HW, Brouwer RW. The role of computer-assisted cryotherapy in the postoperative treatment after total knee arthroplasty: positive effects on pain and opioid consumption. Knee Surg Sports Traumatol Arthrosc. 2022 Aug;30(8):2698-2706. doi: 10.1007/s00167-021-06568-x. Epub 2021 Apr 26. PubMed 33903923 ↗
  • Thijs E, Schotanus MGM, Bemelmans YFL, Kort NP. Reduced opiate use after total knee arthroplasty using computer-assisted cryotherapy. Knee Surg Sports Traumatol Arthrosc. 2019 Apr;27(4):1204-1212. doi: 10.1007/s00167-018-4962-y. Epub 2018 May 3. PubMed 29725749 ↗

Individual participant data

Plan to share: Yes — Only deidentified data will be available upon reasonable written request in conjunction with appropriate data use agreement.

08

Registry details

Key details

Study ID
NCT06730399
Lead sponsor
Martini Hospital Groningen
Responsible party
Sponsor
First posted
Dec 12, 2024
Start date
Aug 1, 2019
Primary completion
Jun 9, 2020
Completion
Mar 23, 2021
Last update
Jan 8, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion